The Significance of Arrhythmias in Athletes (Athlete)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00469794|
Recruitment Status : Unknown
Verified May 2007 by Assaf-Harofeh Medical Center.
Recruitment status was: Recruiting
First Posted : May 7, 2007
Last Update Posted : May 7, 2007
|Condition or disease||Intervention/treatment|
|Sudden Death||Procedure: stress test|
Athletes with complex ventricular arrhythmias are potentially at risk of sudden death. The risk is increased when the athletes are engaged in competitive activities.
Ventricular premature beats (VPB’s) are a common finding in the athletic heart. In the majority of cases these arrhythmias are part of the “athlete’s heart syndrome” and do not increase the risk of sudden death in the athletes with an apparently normal heart. The data available in the literature deal with ventricular arrhythmias assessed only by 24-h ambulatory electrocardiograms.
To date, there are no guidelines concerning athletes who develop ventricular arrhythmias during a stress test. It is unclear whether they should be allowed to continue with their competitive activity or they should be denied to do so. A study looking at the long term follow-up of these athletes will help us determine whether the development of ventricular arrhythmia during a stress test imposes any risk on the athletes.
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Observational Model:||Case Control|
|Observational Model:||Natural History|
|Official Title:||The Long Term Significance of Exercise Induced Ventricular Arrhythmias in Trained Athletes|
|Study Start Date :||May 2006|
|Estimated Study Completion Date :||May 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00469794
|Contact: Therese Fuchs, MDemail@example.com|
|Contact: Zvi Vered, MDfirstname.lastname@example.org|
|Contact: Therese Fuchs, MD 972-8-977-9730 email@example.com|
|Sub-Investigator: Rutie Plitz-Burstein, Ph.D.|
|Principal Investigator:||Therese Fuchs, MD||Assaf-Harofeh Medical Center|